Gleason score and pT-stage. We observed a fourfold increased risk of prostate cancer in men with epithelial CD4 + T regs in the normal prostatic tissue counterpart. T regs seems to facilitate cancer development, due to the critical role of the immune tolerance in the cancer development process. Furthermore high levels of T regs are associated with higher tumor aggressiveness in different types of cancers. 3 Increased numbers of T regs have been observed in a variety of malignancies such as melanoma, 4 ovarian cancer, 5 breast cancer, 6 and renal cancer. 7 A higher prevalence of T regs has also been observed in prostate cancer tissue when compared to normal prostate tissue and has been associated with worse clinical outcome. [8] [9] [10] [11] We recently reported that men with greater number of CD4 + T regs in their prostate tumor environment have an increased risk of dying of prostate cancer. 12 Lymphocyte Activation Gene 3 (LAG-3) has emerged as a marker for was circled with the surrounding stromal tissue and the digital selection was saved in an external hard disk for immunohistochemical scoring.
Conclusions

| Evaluation of CD4/FOXP3, CD8/FOXP3, and LAG-3/FOXP3
We quantified CD4 + T regs by simultaneous CD4 and FOXP3 expression, 
| Statistical analyses
In each area of interest (normal stroma, normal epithelium, PAH (cases), and found that the mean number of T regs was significantly higher in the stroma compared to the epithelia in all compartments, normal (P < 0.001), PAH (P < 0.001), PIN (P < 0.001), and tumor (P < 0.001). However, in contrast to our study, the Valdman et al 9 study utilized immunohistochemistry on tissue micro arrays rather than on triplestained whole mount macro cross-sections and atrophy lesions were not further classified as either simple atrophy or PAH. 
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